Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
By Ben Glickman Elutia is selling its orthobiologics business to Berkeley Biologics, a subsidiary of GNI Group. The company, which makes technologies meant.
MARKET WRAPS Watch For: Housing Starts for August; Canada Consumer Price Index for August; Instacart IPO Today s Top Headlines/Must Reads: - American Business Confidence in China. -September 19, 2023 at 06:11 am EDT
- MarketScreener
U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 200 points on Tuesday. The Dow traded down 0.69% to 34,384.29 while the NASDAQ fell 0.82% to 13,597.78. The S&P 500 also fell, dropping, 0.63% to 4,425.66.